A*cinetobacter* spp. are important opportunistic pathogens closely linked to nosocomial infections, and the most common species from clinical samples is *A. baumannii*, followed by *A. pittii* and *A. nosocomialis*[@b1]. Worldwide increasing emergence of carbapenem-resistant bacteria including *Acinetobacter* has caused concern over the limited availability of effective antimicrobial agents in the clinic.

The most prevalent mechanism of carbapenem resistance in *Acinetobacter* is the elevated expression of OXA-type carbapenemase genes, mainly including the horizontally acquired *bla*~OXA-23~-like, *bla*~OXA-24~-like and *bla*~OXA-58~-like genes as well as the intrinsic *bla*~OXA-51~-like genes[@b2][@b3]. The *bla*~OXA-58~-like and *bla*~OXA-24~-like genes are much less frequently detected relative to the *bla*~OXA-23~-like genes, but they can confer a high level of carbapenem resistance and cause local outbreaks[@b4][@b5][@b6]. The carbapenem hydrolytic activity of OXA-58 can be inhibited by NaCl in a Tyr^144^-Gly-Asn motif-dependent pattern, and this property has been used to screen for the expression of *bla*~OXA-58~[@b7].

At least four types of metallo-β-lactam (MBL) carbapenemase, i.e., IMP, VIM, SIM, and NDM, have been identified in *Acinetobacter*, and these MBLs have lower detection rates but higher carbapenemase activities relative to OXAs[@b8][@b9]. Originally found in *Klebsiella pneumoniae* in 2008, *bla*~NDM~ has been identified globally in many bacteria and received great attention partly due to its high transferability across different bacterial species, its frequent co-occurrence with other resistance genes, and the global spread of *bla*~NDM~-carrying strains[@b10][@b11][@b12][@b13][@b14][@b15]. A large collection of *bla*~NDM~-containing plasmids from different bacterial species have been characterized ([Table S1](#s1){ref-type="supplementary-material"} and the references therein). The *bla*~NDM~ genetic surroundings are commonly composed of IS*Aba125* (intact or truncated) and *ble*~MBL~-*ΔtrpF*, which are upstream and downstream of *bla*~NDM~, respectively, suggesting a similar origin of these *bla*~NDM~ genes detected ([Table S1](#s1){ref-type="supplementary-material"}). Most of the *bla*~NDM~ genetic platforms from *Acinetobacter* are a Tn*125*-related sequence, with a few exceptions containing the truncated forms of this genetic context ([Table S1](#s1){ref-type="supplementary-material"}). Tn*125* is a *bla*~NDM~-containing composite transposon originally described by Pfiefer et al.[@b16], and it has been proposed to be involved in the *bla*~NDM~ genes dissemination in *Acinetobacter*[@b17]. Almost all the well-characterized *bla*~NDM~-containing plasmids from *Acinetobacter* in China are closely related to the plasmid pNDM-BJ01[@b18] by sharing a novel type IV secretion system backbone ([Table S1](#s1){ref-type="supplementary-material"} and references therein).

Coexistence of *bla*~NDM~ and *bla*~OXA~ has been described in *Acinetobacter*, e.g. *bla*~OXA-23~ and *bla*~NDM-1~ in *A. baumannii* from India[@b19] and the Czech Republic[@b20], and *bla*~NDM-1~, *bla*~OXA-23~ and *bla*~IMP~ in *A. baumannii* from China[@b21]. However, it remains unclear whether and how these co-existing carbapenemase genes are expressed to contribute to drug resistance. The present study describes the genetic environment, transferability, and antibiotic susceptibility of *bla*~NDM-1~ and *bla*~OXA-58~ harbored on different plasmids in a single clinical *A. pittii* isolate from China.

Results and Discussion
======================

*bla*~NDM-1~ and *bla*~OXA-58~ on different plasmids in a single *A. pittii* isolate
------------------------------------------------------------------------------------

A total of 31 carbapenem-resistant *Acinetobacter* isolates were collected at the Meizhou People\'s Hospital, Guangdong Province, China, from June 2010 to December 2012. They were classified into *A. pittii* (n = 1, designated 44551), *A*. *nosocomialis* (n = 2), and *A. baumannii* (n = 28). PCR screening for the MBL and OXA carbapenemase genes in these strains indicated the presence of *bla*~NDM-1~ and *bla*~OXA-58~ in strain 44551 and the habitation of *bla*~OXA-23~ in 21 *A. baumannii* isolates (67.7%), while all the other PCR reactions gave negative results. DNA sequencing further confirmed the presence of *bla*~NDM-1~ and *bla*~OXA-58~ in 44551. PCR detection of the extended spectrum β-lactamase genes *bla*~TEM~, *bla*~CTX-M~, *bla*~PER~, *bla*~SHV~, *bla*~DHA~, and *bla*~CMY~[@b22][@b23][@b24][@b25] in 44551 showed negative results. The observation of *bla*~OXA-23~ as the most prevalent carbapenemase gene in *A. baumannii* is consistent with previous findings[@b26].

*A. pittii* 44551 was isolated from the sputum of a 62-year-old male hospitalized for gouty arthritis with a skin soft tissue infection combined with pulmonary tuberculosis (TB) in August 2011. After the initiation of anti-tuberculosis treatment with HREZ (isoniazid, rifampicin, ethambutol hydrochloride, and pyrazinamide), the patient\'s sputum samples were screened weekly for *Mycobacterium tuberculosis*. The patient\'s pulmonary infection symptoms, including fever, weakness and coughing, were relieved in response to anti-TB therapy, and his sputum acid-fast stain gave negative results after two weeks of treatment. After one month of hospitalization, the patient improved perceptibly with stable vital signs. He was discharged with instructions to continue taking 3HREZ/9-12HRZ as prescribed and to undergo regular follow-up. Unfortunately, the patient did not return for regular checkup and has been out of touch with our clinic.

S1-nuclease pulsed-field gel electrophoresis (S1-PFGE) assay ([Fig. 1a](#f1){ref-type="fig"}) showed that *A. pittii* 44551 harbored four different plasmids at \~20 kb, \~40 kb, \~50 kb and \~90 kb. Subsequent Southern hybridization ([Fig. 1b](#f1){ref-type="fig"}) with a probe specific to *bla*~NDM-1~ or *bla*~OXA-58~ revealed that these two genes were located on the \~40 kb (designated pNDM-44551) and \~50 kb (pOXA58-44551) plasmids, respectively. Using the PCR-based replicon typing scheme of *A. baumannii*[@b27], repAci9 was detected in pOXA58-44551 but no classified type of replicase could be identified from pNDM-44551.

Mating out experiments showed that plasmid pNDM-44551 could be transferred from 44551 into *E. coli* J53 and EC600, and *A. baumannii* MZPB at similar frequencies of 2.36 × 10^−2^, 2.81 × 10^−2^, and 3.54 × 10^−2^ per donor cell, respectively. The initial cultures of all the chosen J53 and EC600 conjugant clones and most MZPB clones were *bla*~NDM-1~-positive and *bla*~OXA-58~-negative as revealed by PCR/sequencing. A single resulting conjugant from each of these J53, EC600, and MZPB conjugants, designated J53-44551 EC600-44551, and MZPB-44551, respectively, was selected for S1-PFGE/Southern hybridization ([Fig. 1a and 1b](#f1){ref-type="fig"}). Besides detection of \~40 kb pNDM-44551 in all the tested conjugants, an additional *bla*~NDM-1~-positive signal at \~80 kb was found in J53-44551 and EC600-44551, suggesting that a recombination event occurred for pNDM-44551 upon conjugal transfer from *Acinetobacter* to *Enterobacteriaceae*. The above observations denoted high self-transferability of pNDM-44551 across multiple bacterial species.

A weak PCR signal of *bla*~OXA-58~ was observed in a small portion of the *bla*~NDM-1~-positive MZPB-44551 clones at a 1:10 ratio, as well as in their passage cultures, which was further confirmed by sequencing. Meanwhile, Random Amplified Polymorphic DNA showed that these *bla*~OXA-58~- and *bla*~NDM-1~-positive conjugants were MZPB-originated species. The PCR results of one of the above conjugants, designated MZPB-44551^OXA58+^, were shown in [Fig. S1a and S1b](#s1){ref-type="supplementary-material"}. Nonetheless, the pOXA58-44551 signal was invisible by S1-PFGE/Southern hybridization in MZPB-44551^OXA58+^ ([Fig. 1a](#f1){ref-type="fig"}), which was attributable to the very low copy number of pOXA58-44551. In addition, no PCR signal of *bla*~OXA-58~ was detected in all the *bla*~NDM-1~-haboring J53 or EC600 conjugants tested, which is consistent with the fact that *bla*~OXA-58~ has only been found in *Acinetobacter*[@b28]. In all, it seemed that pOXA58-44551 could co-transfer with pNDM-44551 only into the *Acinetobacter* recipient.

Plasmid pBBRIMCS3-NDM-1, containing the IS*Aba125*-*bla*~NDM-1~ fragment cloned from pNDM-44551, was transformed into *E. coli* DH5α, and the resulting transformant clone was named DH5α-NDM1. All clones of 44551, DH5α-NDM1, J53-44551, and EC600-44551 showed high resistance to the penicillin/cephalosporin drugs tested. 44551 and DH5α-NDM1 also displayed high resistance to IPM and MEM, but J53-44551 and EC600-44551 remained susceptible to these two carbapenem drugs ([Table 1](#t1){ref-type="table"}). Therefore, we speculated that more functional NDM-1 proteins might be present in 44551 and DH5α-NDM1 than in J53-44551 and EC600-44551, although there was no discernible difference in the pNDM-44551 copy number among these strains ([Fig. 1a and 1b](#f1){ref-type="fig"}). This speculation was supported by the northern blot and quantitative reverse-transcription PCR (RT-qPCR) assays, which showed that the *bla*~NDM-1~ mRNA abundance in 44551 or DH5α-NDM1 was much higher than that in J53-44551 or EC600-44551 ([Fig. S2](#s1){ref-type="supplementary-material"}).

It is worth noting that MZPB-44551 showed distinct antimicrobial susceptibility profile from 44551 across almost all the tested β-lactams ([Table 1](#t1){ref-type="table"}), while the pNDM-44551 copy number ([Fig. 1a](#f1){ref-type="fig"}) or the *bla*~NDM-1~ mRNA abundance ([Fig. S2](#s1){ref-type="supplementary-material"}) was comparable between these two strains. Based on the spontaneous PB-resistance of MZPB under PB selection, it is reasonable to speculate that this distinction may be mainly due to different species backgrounds.

Genetic surroundings of *bla*~NDM-1~
------------------------------------

pNDM-BJ01 was recovered from *A. lwoffii* in China in 2012 and harbored four regions encoding for conjugate transfer, plasmid replication and stability, a type IV secretion system, and the *bla*~NDM-1~ gene cluster[@b18]. Primer walking combined PCR/sequencing indicated that pNDM-44551 contained 41 of the 46 CDSs annotated in pNDM-BJ01 with \>99% sequence identity and the missing five CDSs were located in a tandem manner within the *bla*~NDM-1~ gene cluster.

The *bla*~NDM-1~ gene cluster of pNDM-44551 was arranged sequentially as *orfA* and *orfB* of IS*Aba14*, *aphA6*, IS*Aba125*, *bla*~NDM-1~, *ble*~MBL~, *ΔtrpF*, *dsbC*, *tnpR*, and *zeta* from left to right; a five-gene region (*cutA*, *ΔgroS*, *groEL*, *insE*, and IS*Aba125*) located between *dsbc* and *tnpR* of pNDM-BJ01 was absent from pNDM-44551; the cleavage of the above DNA region led to a 97 bp 3′-remnant (GC content ≈ 60%) of the *cutA* coding region (CDS) to be spliced directly with a 372 bp 3′-flanking sequence (GC content ≈ 40%) of *tnpR* at the junction site AGGGAT-ATATAG, generating a 'new\' *dsbC*-*tnpR* intergenic region in pNDM-44551 ([Fig. 2a](#f2){ref-type="fig"}).

The *aphA6* gene was usually found adjacently upstream of the IS*Aba125*-*bla*~NDM-1~ structure in the pNDM-BJ01-like plasmids ([Table S1](#s1){ref-type="supplementary-material"}). It has been postulated that a Tn*125* transposon structure inserts into the non-coding region downstream of *aphA6*, which is evidenced by the 3-bp GTT target site duplication at the point of insertion as shown in pNDM-BJ01[@b18]. A 64 bp direct repeat was observed flanking the IS*Aba125*-*bla*~NDM-1~ insertion in pNDM-44551, and each monomer was composed of the first 20 bp of the CDS of *aphA6* or *bla*~NDM-1~ together with its upstream 44 bp sequence ([Fig. 2a](#f2){ref-type="fig"}), which was consistent with the previous report that *bla*~NDM-1~ is a chimeric gene resulted from the in-frame fusion of a preexisting *bla*~NDM-1~ with *aphA6*[@b29].

A total of 11 single nucleotide polymorphism (SNP) sites were present in the *aphA6* CDS of pNDM-44551 relative to pNDM-BJ01, resulting in three amino acid (a.a.) changes of L84F, A156T, and R163K. In addition, a 67 bp deletion occurred within the 3′ flanking region of *aphA6* of pNDM-44551 compared with pNDM-BJ01 ([Fig. 2b](#f2){ref-type="fig"}). The *aphA6* CDS together with its 3′ flanking region of pNDM-44551 was almost identical to the counterpart of Tn*aphA6* (accession number JF343537, located in the chromosome of *A. baumannii* from Australia) and that of pWH8144 (accession number JG241792, in *A. baumannii* from China), with only one SNP mismatch (T to C) at the 5′ end of *aphA6*. By contrast, this kind of *aphA6* gene considerably differed from the counterpart of pNDM-BJ01 ([Fig. 2b](#f2){ref-type="fig"}). *aphA6* has been proposed to be an ancestral gene in *Acinetobacter* and possesses considerable nucleotide polymorphism[@b30]. There might be two possible explanations for the aforesaid *aphA6* sequence difference: 1) the original recombination of *aphA6* with *bla*~NDM-1~ may be two independent events in pNDM-44551 and pNDM-BJ01, and 2) homologous recombination may occur to induce an *aphA6* swap upon the spread of the *aphA6*-IS*Aba125*-*bla*~NDM-1~-containing plasmid into an *aphA6*-carrying *Acinetobacter* strain.

The above observations strongly suggest that pNDM-44551 represents a close derivate of pNDM-BJ01 although pNDM-44551 might have undergone multiple evolutionary events especially within the *bla*~NDM-1~ gene cluster. An array of the pNDM-44551 variants have been characterized in *Acinetobacter* from the mainland of China, such as pXBC1 in *A. johnsonii*[@b31], pNDM-AB in *A. baumannii*[@b32], and pAP-D499 in *A. pittii*[@b33]. The major genetic differences in the above plasmids were confined in the surrounding regions of *bla*~NDM-1~ ([Table S1](#s1){ref-type="supplementary-material"}). It should be noted that the IS*Aba125* element upstream of *bla*~NDM-1~ is usually intact in *Acinetobacter* but often truncated in *Enterobacteriaceae* ([Table S1](#s1){ref-type="supplementary-material"}), suggesting the probable spread of the *bla*~NDM-1~ genetic platforms from *Acinetobacter* to *Enterobacteriaceae*[@b13][@b18][@b29][@b34]

Genetic surroundings of silent *bla*~OXA-58~
--------------------------------------------

In general, *bla*~OXA-58~ is embedded in a conserved platform IS*Aba3*-like-*bla*~OXA-58~-IS*Aba3* in *Acinetobacter*, and the upstream IS*Aba3*-like element is often interrupted by other insertion sequence (IS) elements, which in turn provide the promoters enhancing the *bla*~OXA-58~ expression to mediate higher degrees of drug resistance compared with the parent intact IS*Aba3*-like[@b35][@b36][@b37][@b38][@b39]. Sequence analysis revealed that the *bla*~OXA-58~ gene of pOXA58-44551 was located between a downstream IS*Aba3* and an upstream IS*Aba3*-like, both of which were intact; the downstream IS*Aba3* was followed by a gene cluster *aaC3* (aminoglycoside N3′-acetyltransferase III)-*ATPase* (ATPase protein) ([Fig. 3](#f3){ref-type="fig"}), which differed from the previously reported common pattern *araC1* (transcription regulator)-*lysE* (threonine efflux protein) in *bla*~OXA-58~ genetic contexts in *Acinetobacter* spp. from China[@b40] and other countries[@b39][@b41]. The C-terminal 23 a.a. sequence of the transposase of the upstream IS*Aba3*-like element in pOXA58-44551 was replaced with an unknown 26 a.a. fragment, and moreover the 3′-untranslated region (3′-UTR) and the right inverted repeat (IRR) were lost ([Fig. 3](#f3){ref-type="fig"}). This entire upstream IS*Aba3*-like element was essentially the same as the counterpart in the *bla*~OXA-58~ genetic structure in an *A. pittii* isolate AP04 from China[@b40] and some unpublished *bla*~OXA-58~-containing sequences (accession numbers JX101647, FJ195389 and FJ200187), as well as in a *bla*~OXA-97~ genetic structure[@b36]. In addition, a 372 bp DNA fragment (named *372F*) as the left neighbor of the upstream IS*Aba3*-like element in pOXA58-44551 ([Fig. 3](#f3){ref-type="fig"}) showed 100% sequence identity to that in the genome of the insect *Dendroctonus ponderosae* (APGK01007886.1). In all, *bla*~OXA-58~ was mobilized into the genetic platform *372F*-IS*Aba3*-like-*bla*~OXA-58~-IS*Aba3* (flanked by the 28 bp direct repeat; having a GC content much lower than those of the surrounding regions), which was further inserted into the backbone of pOXA58-44551 most likely through IS-mediated transposition.

The evidences described below from different aspects denoted that *bla*~OXA-58~ was expressed either very weakly or not at all in 44551. First, the addition of EDTA (the inhibitor of MBLs including NDM1) in the agar plates for bacterial cultivation made 44551 lose almost the entire resistance to the tested β-lactams, but the addition of excess NaCl (the inhibitor of OXA-58) had no effect on the resistance profile of 44551 ([Table 1](#t1){ref-type="table"}), indicating that the production of NDM-1 enzyme contributed the majority to β-lactams resistance while *bla*~OXA-58~ contributed little to the resistance. Second, the IS*Aba3*-like element upstream of *bla*~OXA-58~ in pOXA58-44551 was intact, suggesting a lack of the *bla*~OXA-58~-driven promoter which was usually provided by other inserted IS elements in the typical OXA-58-encoding genetic structures[@b35][@b36][@b37][@b38][@b39] ([Fig. 3](#f3){ref-type="fig"}). This postulation was further supported by a recent surveillance study, which showed that as many as 25 of the total of 32 *bla*~OXA-58~-positive *Acinetobacter* isolates recovered from 23 Chinese provinces remained susceptible to carbapenems, and all of them contained an intact IS*Aba3*-like element upstream of *bla*~OXA-58~, while the remaining non-susceptible isolates showed an insertion of additional IS element into the upstream IS*Aba3*-like element[@b42]. Third, repeated attempts to transform the plasmid pBBRIMCS3-OXA-58 (containing the IS*Aba3*-like-*bla*~OXA-58~ fragment cloned from pOXA58-44551) into *E. coli* DH5α failed to generate an ampicilin-resistant, *bla*~OXA-58~-haboring clone. Finally, northern blot with a probe specific to *bla*~OXA-58~ showed very weak or almost invisible signals in *A. pittii* 44551, but a very strong band could be detected in the BL21-OXA58 strain, which was an *E. coli* BL21 strain carrying the plasmid pET-28a-*bla*~OXA58~ ([Fig. 4a and 4b](#f4){ref-type="fig"}). Consistent with the northern blot results, RT-qPCR assay revealed that the relative mRNA abundance of *bla*~OXA-58~ in strain 44551 was about 30-fold lower than that in BL21-OXA58, with the 16S rRNA genes being the internal control ([Fig. 4c](#f4){ref-type="fig"}).

Concluding remarks
------------------

In the present study, *bla*~NDM-1~ and *bla*~OXA-58~ were found to be harbored on two different plasmids in a single clinical *A*. *pittii* isolate named 44551, with the former gene expressing well and the latter one silent. Each of these two resistance genes was embedded in a genetic structure differing partly from its previously characterized variants. The *bla*~NDM-1~-carrying plasmid in 44551, conferring a high level of carbapenem resistance, showed a strong ability of horizontal transfer into *Acinetobacter* and *Enterobacteriaceae*. The silent *bla*~OXA-58~ has the potential to evolve into the active form due to additional IS element insertion driven by environmental pressures such as the presence of carbapenems. The fact that *A. pittii* 44551 colonized in the lower respiratory tract of the indicated hospitalized patient increased the possibility of the strain 44551 dissemination into hospital settings. Since the *Acinetobacter* strains co-harboring *bla*~NDM-1~ (active) and *bla*~OXA-58~ (either active or silent) have the potential to widely spread in China[@b42], increased surveillance of these kinds of bacteria in hospital and community settings is urgently needed.

Methods
=======

Clinical Acinetobacter isolates
-------------------------------

Each clinical sample was inoculated onto MacConkey agar plates and the dominant strain was recovered and identified using Vitek II (BioMérieux, Durham). Discrimination of *Acinetobacter* was performed by one-tube multiplex PCR specific for *A. baumannii* identification[@b43] and by 16S-23S rRNA intergenic spacer sequencing for other types of *Acinetobacter*[@b44]. All the primers used in this study are listed in [Table S2](#s1){ref-type="supplementary-material"}.

Detection of carbapenemase genes and their genetic contexts
-----------------------------------------------------------

The MBL genes *bla*~IMP~, *bla*~VIM~, *bla*~SIM~, and *bla*~NDM~ were screened by multiplex PCR[@b45]. The OXA genes *bla*~OXA-23~, *bla*~OXA-24~, and *bla*~OXA-58~ were detected individually by PCR. The plasmid sample was prepared from 44551 using a BAC/PAC DNA Isolation Maxi Kit (Omega Bio-Tek), and the flanking regions were sequenced by primer walking from both ends of *bla*~NDM-1~ or *bla*~OXA-58~. All PCR amplicons were subjected to DNA sequencing with an ABI 3700 sequencer.

Plasmid construction and electrotransformation
----------------------------------------------

The *bla*~NDM-1~ or *bla*~OXA-58~ coding region together with its immediately upstream IS element was amplified from 44551 and then cloned into the cloning vector pBBRIMCS3[@b46], generating the recombinant plasmid pBBRIMCS3-NDM-1 or pBBRIMCS3-OXA-58, respectively. The entire coding region of *bla*~OXA-58~ was cloned into the expression vector pET-28a, generating pET-28a-*bla*~OXA-58~. pBBRIMCS3-NDM-1 or pBBRIMCS3-OXA-58 was transformed into *E. coli* DH5α through electrotransformation, while pET-28a-*bla*~OXA-58~ was transformed into *E. coli* BL21, with an attempt to obtain the *E. coli* clone expressing the corresponding carbapenemase enzyme.

Conjugal transfer
-----------------

*A. pittii* 44551 harboring *bla*~NDM-1~ and *bla*~OXA-58~ was used as the donor, and *E. coli* J53 (NaN~3~ resistant), EC600 (rifampin resistant), and *A. baumannii* MZPB were used as the recipients. MZPB is a homemade polymyxin-resistant derivate of a clinical isolate *A. baumannii* MZ and remains susceptible to β-lactams. Membrane mating experiments were performed on Mueller-Hinton (MH) agar[@b47]. After 18 h of incubation, the mixed cultures were suspended in MH broth, and plated onto MH agar containing ampicillin (50 μg/ml) and NaN~3~ (200 μg/ml) for J53, ampicillin (50 μg/ml) and rifampin (500 μg/ml) for EC600, and ampicillin (50 μg/ml) and polymyxin (20 μg/ml) for MZPB. Conjugants were picked randomly from the original selective plates and inoculated into the selective LB broth, these initial cultures were used for PCR-based screening for the presence of *bla*~NDM-1~ and *bla*~OXA-58~. To exclude the donor strain contamination, the initial culture of positive conjugants were spread onto the Amp^+^/PB^+^ plate, then the second-passage colonies were randomly picked for each strain and subjected for PCR detection of *bla*~NDM-1~ and *bla*~OXA-58~. The strain species were differentiated by Random Amplified Polymorphic DNA with two short primers M13 and AP2[@b48].

Antimicrobial susceptibility testing
------------------------------------

The MIC values for each indicated strain cultured on the MH plates were measured using Etest (AB bioMérieux, Solna, Sweden). The results were interpreted according to the Clinical and Laboratory Standards Institute (CLSI) guidelines and the British Society for Antimicrobial Chemotherapy (SAC) breakpoints[@b49][@b50].

S1-PFGE and Southern blot
-------------------------

Bacterial genomic DNA was prepared in agarose plugs and digested with S1 nuclease (Takara). The linearized plasmids and partially digested genomic DNA were separated through the CHEF-Mapper XA PFGE system (Bio-Rad). The DNA fragments were stained with ethidium bromide (EtBr), transferred to a Hybond N+ membrane (GE Amersham Biosciences) and hybridized with the DIG-labeled probe specific to *bla*~NDM-1~ or *bla*~OXA-58~. Probe labeling and signal detection were carried out with DIG high primer DNA labeling and detection starter kit II according to the manufacturer\'s instructions (Roche Diagnostics).

RNA extraction and Northern blot
--------------------------------

By using Trizol Reagent (Life Technologies), total RNA was isolated from the overnight culture of each indicated strain with or without addition of 1 mM IPTG. The RNA samples were analyzed on a formaldehyde-containing 1.2% agarose gel. Subsequent EtBr staining, membrane transfer, probe labeling and hybridization, and signal detection were carried out as above.

RT-qPCR
-------

5 μg of RNA treated with DNase I (Promega) was subjected to reverse transcription by using random hexamers and PrimeScript RT reagents (Takara). Simultaneously, a control reverse transcription reaction without reverse transcriptase was performed to rule out genomic DNA contamination. The cDNA reactions were diluted 1:5 in water as the template for PCR detection of *bla*~NDM-1~ or *bla*~OXA-58~, and diluted 1:500 for amplification of the 16S rRNA genes. Each PCR reaction contained 2 μl of cDNA, 8 μl of forward and reverse primers (each at 0.75 μM), and 10 μl of SYBR green PCR Supermix (Bio-Rad). Three independent bacterial cultures (total RNA samples) were employed as biological replicates, and each RNA sample was analyzed in triplicate in PCR. The PCR parameters were 95°C for 10 min, followed by 40 cycles of 95°C for 5 s and 60°C for 30 s, using Bio-Rad CFX96 thermocycler. The detecting mRNA levels of *bla*~NDM-1~ or *bla*~OXA-58~ were normalized to those of the 16S rRNA genes.

Plasmid replicon typing
-----------------------

Plasmid pOXA58-44551 was recovered from the S1-PFGE gel and used as the template for PCR detection of replicase genes using the *A. baumannii* PCR-based replicon typing scheme[@b27]. The variants belonging to the same group of replicases were recognized by further PCR amplicon sequencing.

Nucleotide sequence accession numbers
-------------------------------------

The *bla*~NDM-1~ or *bla*~OXA-58~ gene cluster reported herein was deposited in GenBank with the accession number KF208467 or KF208466, respectively.
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![S1-PFGE and Southern blot assay of strain 44551 and its conjugants.\
Shown are EtBr-stained PFGE gel of S1-digested of genomic DNA samples (a), and subsequent Southern blot hybridization with the DIG-labeled probe specific to *bla*~NDM-1~ (b) or *bla*~OXA-58~ (c). The white arrow and star indicate the locations of *bla*~OXA-58~- and *bla*~NDM-1~-positive signals, respectively. Lane 1: 44551; 2: J53; 3: J53-44551; 4: EC600; 5: EC600-44551; 6: MZPB; 7: MZPB-44551; 8: MZPB-44551^OXA58+^; M: marker.](srep08976-f1){#f1}

![Schematic alignment of *bla*~NDM-1~ genetic surroundings.\
Genes and their transcriptional orientations are represented by differently patterned horizontal arrows. *orfA* and *orfB*: *ISAba*14 transposase; *aphA6*: aminoglycoside 3′-phosphotransferase; *bla*~NDM-1~: New Delhi metallo-β-lactamase 1; *ble*~MBL~: bleomycin resistance protein; *ΔtrpF*: truncated phosphoribosylanthranilate isomerase; *dsbC*: tat twin-arginine translocation pathway signal sequence domain protein; *cutA*: periplasmic divalent cation tolerance protein; *ΔgroS* and *groEL*: chaperonin subunits; ins*E*: IS*CR3* transposase. (a) The *bla*~NDM-1~ gene clusters from pNDM-44551 and pNDM-BJ01. The identical DNA regions are shaded in gray, the GC skew is shown with a sliding window of 100 nucleotides, and the primers used for PCR/sequencing are marked with thin black arrows as well as corresponding primer names. (b) Schematic showing the sequence differences of *aphA6* CDSs and their 3′ flanking regions from pNDM-BJ01, pNDM-44551, and Tn*aph6*.](srep08976-f2){#f2}

![Schematic alignment of *bla*~OXA-58~ genetic surroundings.\
Shown are the *bla*~OXA-58~ gene cluster from pOXA58-44551 (upper panel), and that of the most common pattern (lower panel) characterized previously[@b35][@b36][@b37][@b38][@b39][@b40]. Genes and their transcriptional orientations are represented by horizontal arrows. The primers used for PCR/sequencing are marked with thin black arrows as well as corresponding primer names.](srep08976-f3){#f3}

![Detection of *bla*~NDM-1~ and *bla*~OXA-58~ transcripts.\
Total RNAs were extracted from strains 44551, BL21-NDM and BL21-OXA58. RNA samples were analyzed on 1.2% agarose gel followed by EtBr staining, and then subjected to Northern blot hybridization with the DIG-labeled probe specific to *bla*~NDM-1~ (a) and *bla*~OXA-58~ (b). IPTG was added in the cell cultures to induce the expression of *bla*~NDM-1~ or *bla*~OXA-58~. Lane 1: 44551; 2: BL21-NDM in the absence of IPTG; 3: BL21-NDM in the presence of IPTG; 4: BL21-OXA58 in the absence of IPTG; 5: BL21-OXA58 in the presence of IPTG. The calculated size of *bla*~NDM-1~ or *bla*~OXA-58~ transcript is about 1 kb. The EtBr staining of the 23S and 16S rRNA genes (2.9 kb and 1.5 kb, respectively) was used as loading control (lower panels). The relative mRNA abundances of *bla*~NDM-1~ or *bla*~OXA-58~ in 44551, BL21-NDM and BL21-OXA58 induced with IPTG, respectively, were detected by RT-qPCR (c). The 16S rRNA genes of 44551 and BL21 were employed as the internal control. The normalized mRNA abundance of *bla*~NDM-1~ in 44551 was set as 1. Results are expressed as mean ± SD.](srep08976-f4){#f4}

###### Antimicrobial susceptibility profiles

  Strain                 MIC (μg/ml)                                                                                                      
  --------------------- ------------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ---- ------- ------ ------- -------
  44551                      24        \>256    24     \>256   \>256   \>256   \>32    \>32      4      24     64   \>32    0.50   0.023   0.125
  J53-44551                 \>256       32      64     \>256    32      1.0     1.5      1     0.23    0.125   1    0.008   0.5    0.75    0.064
  J53                         2        0.125   0.032   0.125   0.125   0.047   0.38    0.064   0.047   0.125   1    0.008   0.38   0.75    0.064
  EC600-44551               \>256       64      48     \>256    96       4       3       2     0.047   0.25    2    0.094   0.38    1.0    0.047
  EC600                       2         1.5    0.094   0.25    0.125   0.064   0.38    0.023   0.047   0.25    2    0.125   0.19   0.75    0.047
  MZPB-44551                  1          2     0.094    128     96       4       2       2       4     0.125   1    0.032    20    0.023   0.064
  MZPB                        1          2     0.094     2       2       1     0.094   0.094     4     0.125   1    0.032    20    0.023   0.064
  DH5α-NDM1                 \>256      \>256   \>256   \>256   \>256   \>32     16      12     0.047   0.125   1    0.008   0.38   0.75    0.064
  DH5α                        2        0.125   0.032   0.25    0.125   0.064   0.38    0.064   0.047   0.125   1    0.008   0.38   0.75    0.064
  44551 (100 μM EDTA)        0.5        0.5    0.125     1     0.38     0.5    0.38    0.38      4      24     64   \>32    0.5    0.023   0.125
  44551 (200 mM NaCl)        16         64      16     \>256   \>256   \>256   \>32    \>32      4      24     64   \>32    0.5    0.023   0.125

AB, penicillin/sulbactam; TZP, piperacillin/tazobactam; SCF, cefoperazone/sulbactam 2:1; CAZ, ceftazidime; CTX, cefotaxime; FEP, cefepime; IPM, imipenem; MEM, meropenem; ATM, aztreonam; GEN, gentamicin; AMK, amikacin; CIP, ciprofloxacin; PMB, polymyxin B; MIN, minocycine; TGC, tigecycline. 44551 (100 μM EDTA), and 44551 (200 mM NaCl): cultivation of 44551 on the MH plates containing 100 μM EDTA, and 200 mM NaCl, respectively.

[^1]: These authors contributed equally to this work.
